Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry
Keywords: فیلتر نقص جرمی; Remimazolam; Metabolites; UPLC/SYNAPT-HDMS; Mass defect filter;